FindTrial
Sign In

The Efficacy and Safety of The Paul Glaucoma Implant in the Treatment of Refractory Childhood Glaucoma

The Efficacy and Safety of The Paul Glaucoma Implant in the Treatment of Refractory Childhood Glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096244
Enrollment
Unknown
Registered
2025-01-21
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children who received PGI treatment during the study period were followed up for at least three months; and their clinical case data were complete.

Exclusion criteria

Exclusion criteria: 1.The patient was lost to follow-up, unwilling to continue with the follow-up or provide follow-up data. 2.The PGI was removed. 3.The patient underwent other glaucoma surgeries to control intraocular pressure.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;—

Secondary

MeasureTime frame
Complete success;Qualified success;Failure;The number of antiglaucoma medications;—

Countries

China

Contacts

Public ContactYuan Zhilan

Department of Ophthalmology,the First Affiliated Hospital of Nanjing Medical University

zhilanyuan@vip.sina.com+86 133 2781 3333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026